Krsnaa Diagnostics Limited (IN:KRSNAA)
:KRSNAA
Want to see IN:KRSNAA full AI Analyst Report?
KRSNAA Stock Chart & Stats
₹735.10
₹3.75(0.41%)
At close: 4:00 PM EST
₹735.10
₹3.75(0.41%)
Day’s Range― - ―
52-Week Range₹502.20 - ₹891.80
Previous CloseN/A
Volume110.72K
Average Volume (3M)12.28K
Market Cap
₹18.82B
Enterprise Value₹21.60B
Total Cash (Recent Filing)₹1.60B
Total Debt (Recent Filing)₹2.86B
Price to Earnings (P/E)38.4
Beta1.07
Next Earnings
Jun 03, 2026EPS Estimate
2.45Next Dividend Ex-DateN/A
Dividend Yield0.38%
Share Statistics
EPS (TTM)4.90
Shares Outstanding32,438,670
10 Day Avg. Volume19,408
30 Day Avg. Volume12,281
Financial Highlights & Ratios
PEG Ratio0.98
Price to Book (P/B)2.95
Price to Sales (P/S)3.63
P/FCF Ratio-66.26
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)52.72
Revenue Forecast (FY)₹10.45B
Bulls Say, Bears Say
Bulls Say
High Gross MarginsSustained gross margins near 76% indicate durable pricing power and efficient test-cost structure across pathology and imaging. This margin buffer supports profitability through tariff variability, funds expansion of lab network, and improves operating leverage as volumes scale over months.
Low Financial LeverageA conservative capital structure with low leverage provides financial flexibility to bid PPP contracts, fund equipment, and withstand revenue seasonality. Strong equity base reduces refinancing risk and supports capital allocation for network growth without stressing solvency over 2–6 months.
Recurring PPP Institutional Revenue ModelA business model anchored in PPPs and hospital/service contracts creates repeatable, contract-backed volumes and predictable revenue streams. Combined with a growing center network, this structural demand supports stable utilization and multi-location feed to central labs over the medium term.
Bears Say
Negative Free Cash FlowNegative FCF despite solid operating cash conversion signals that investment timing and capital deployment are outpacing cash generation. Persisting FCF deficits can limit organic reinvestment, slow deleveraging, or force external funding, affecting financial resilience over coming quarters.
Capex Intensity From Network ExpansionSetting up diagnostic centers and imaging equipment is capital intensive, driving capex that depresses free cash flow. If expansion cadence remains high, recurring capex needs will constrain cash available for margins improvement, dividend policy, or opportunistic investments in the near term.
Modest Return MetricsModerate ROE and mid-single-digit to low-double-digit margins suggest room to better convert revenue growth into shareholder returns. Without margin expansion or improved asset efficiency, incremental revenue may yield limited improvement in returns over the next several quarters.
Krsnaa Diagnostics Limited News
KRSNAA FAQ
What was Krsnaa Diagnostics Limited’s price range in the past 12 months?
Krsnaa Diagnostics Limited lowest stock price was ₹502.20 and its highest was ₹891.80 in the past 12 months.
What is Krsnaa Diagnostics Limited’s market cap?
Krsnaa Diagnostics Limited’s market cap is ₹18.82B.
When is Krsnaa Diagnostics Limited’s upcoming earnings report date?
Krsnaa Diagnostics Limited’s upcoming earnings report date is Jun 03, 2026 which is in 34 days.
How were Krsnaa Diagnostics Limited’s earnings last quarter?
Krsnaa Diagnostics Limited released its earnings results on Feb 05, 2026. The company reported ₹4.9 earnings per share for the quarter, missing the consensus estimate of ₹6.067 by -₹1.167.
Is Krsnaa Diagnostics Limited overvalued?
According to Wall Street analysts Krsnaa Diagnostics Limited’s price is currently Overvalued.
Does Krsnaa Diagnostics Limited pay dividends?
Krsnaa Diagnostics Limited pays a Annually dividend of ₹2.75 which represents an annual dividend yield of 0.38%. See more information on Krsnaa Diagnostics Limited dividends here
What is Krsnaa Diagnostics Limited’s EPS estimate?
Krsnaa Diagnostics Limited’s EPS estimate is 2.45.
How many shares outstanding does Krsnaa Diagnostics Limited have?
Krsnaa Diagnostics Limited has 32,438,670 shares outstanding.
What happened to Krsnaa Diagnostics Limited’s price movement after its last earnings report?
Krsnaa Diagnostics Limited reported an EPS of ₹4.9 in its last earnings report, missing expectations of ₹6.067. Following the earnings report the stock price went down -0.776%.
Which hedge fund is a major shareholder of Krsnaa Diagnostics Limited?
Currently, no hedge funds are holding shares in IN:KRSNAA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Krsnaa Diagnostics Limited
Krsnaa Diagnostics Limited provides diagnostic services. The company offers a range of technology-enabled diagnostic services, such as radiology, pathology/clinical laboratory, and tele-radiology services to public and private hospitals, medical colleges, and community health centers. As of December 31, 2020, it operated 1,801 diagnostic centers in 13 states across India. The company was incorporated in 2010 and is based in Pune, India.
Technical Analysis
Dr. Lal PathLabs Limited
―
Metropolis Healthcare Ltd.
―
Suraksha Diagnostic Ltd.
―
Thyrocare Technologies Ltd
―
Vijaya Diagnostic Centre Ltd.
―